price
AR
NASDAQ · ARCT
Arcturus Therapeutics Holdings Inc.
Healthcare · Biotechnology
$15.84
Down-$0.24 (-1.52%)
Updated Sep 16, 2026, 10:15 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 233.85M
- P/E ratio
- -3.35
- Dividend yield
- 0.00%
- 52-week range
- $5.50 – $24.17
- Volume
- 556.18K
- Avg. volume
- 553.54K
Price performance
ARCT price history
1M range · 20 trading sessions · Daily adjusted prices
ARCT closed at $15.84 after 20 trading sessions, up 92.94% for the selected period.
- Last close
- $15.84
- Period change
- +92.94%
- Period low
- $8.21
- Period high
- $16.74
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $15.335 | $15.99 | $14.755 | $15.84 | 556.18K |
| Sep 14, 2026 | $14.62 | $15.53 | $14.42 | $15.29 | 596.19K |
| Sep 11, 2026 | $14.06 | $15.1242 | $14.06 | $14.73 | 496.64K |
| Sep 10, 2026 | $14.29 | $14.33 | $13.12 | $13.98 | 944K |
| Sep 9, 2026 | $15.46 | $15.46 | $14.46 | $14.74 | 723.05K |
| Sep 8, 2026 | $15.47 | $15.855 | $14.765 | $15.63 | 641.47K |
| Sep 4, 2026 | $15.61 | $16.02 | $15.40 | $15.82 | 534.62K |
| Sep 3, 2026 | $16.77 | $16.99 | $15.34 | $15.56 | 849.07K |
| Sep 2, 2026 | $16.46 | $17.7497 | $15.45 | $16.74 | 2.02M |
| Sep 1, 2026 | $14.87 | $16.85 | $14.8575 | $16.225 | 1.37M |
| Aug 31, 2026 | $15.00 | $15.65 | $14.00 | $14.76 | 1.26M |
| Aug 28, 2026 | $15.43 | $15.90 | $14.491 | $15.19 | 1.62M |
| Aug 27, 2026 | $15.74 | $16.59 | $15.43 | $16.17 | 1.13M |
| Aug 26, 2026 | $15.35 | $16.49 | $14.73 | $15.83 | 2.23M |
| Aug 25, 2026 | $14.12 | $16.24 | $14.12 | $15.44 | 2.21M |
| Aug 24, 2026 | $13.325 | $14.53 | $12.42 | $14.34 | 2.41M |
| Aug 21, 2026 | $11.13 | $13.50 | $11.11 | $13.45 | 2.86M |
| Aug 20, 2026 | $10.08 | $11.4736 | $10.061 | $10.99 | 2.29M |
| Aug 19, 2026 | $9.405 | $11.10 | $9.33 | $10.28 | 5.63M |
| Aug 18, 2026 | $8.03 | $8.49 | $8.03 | $8.21 | 403.15K |
Latest ARCT news
The latest Smart Investors Daily articles mentioning ARCT.
Stock researchCompany · Financials
Loading stock research…